Please use this identifier to cite or link to this item: http://earchive.tpu.ru/handle/11683/132443
Title: Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation
Authors: Popov, Alexander
Suvorov, Nikita
Larkina, Mariya Sergeevna
Plotnikov, Evgeny Vladimirovich
Varvashenya, Ruslan Nikolaevich
Bodenko, Vitalina Vasiljevna
Yanovich, Gleb
Ostroverkhov, Petr
Usachev, Maxim
Filonenko, Elena
Belousov, Mikhail Valerjevich
Grin, Mikhail
Keywords: technetium-99m; chlorin; radiopharmaceuticals; HYNIC; cancer
Issue Date: 2025
Publisher: MDPI AG
Citation: Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation / Alexander Popov, Nikita Suvorov, Mariia Larkina [et al.] // Molecules. — 2025. — Vol. 30, iss. 1. — Article number 117, 17 p..
Abstract: The use of radiopharmaceuticals for diagnostics in oncology allows for the detection of the disease at an early stage. Among diagnostic radionuclides, 99mTc is a promising isotope that has been used to create several drugs for clinical use. One of the most effective 99mTc chelators is 6-hydrazinylnicotinic acid (HYNIC), which, when combined with various vector molecules, can be used for targeted delivery of radionuclides to tumor tissues. At the same time, it is known that tetrapyrrole macrocycles are capable of selective accumulation in tumors, and thus can be used to target radiopharmaceuticals with 99mTc. In this work, the conjugate of natural chlorin and HYNIC was obtained, and preliminary preclinical studies were carried out on its radiocomplex with 99mTc
URI: http://earchive.tpu.ru/handle/11683/132443
Appears in Collections:Репринты научных публикаций

Files in This Item:
File SizeFormat 
reprint-679724.pdf1,54 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons